NASDAQ · LIVN
LivaNova PLC
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for LIVN: Nov 04, 2026
LivaNova PLC Ordinary Shares is expected to report earnings on 11/04/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $0.9. The reported EPS for the same quarter last year was $0.97.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.90 | $0.90 | $0.90 | 2 |
| Dec 2026 | $0.94 | $0.95 | $0.92 | 2 |
| Mar 2027 | $0.94 | $0.94 | $0.94 | 1 |
| Jun 2027 | $1.02 | $1.02 | $1.02 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · MarketBeat- Zacks · Oct 28, 6:30 PM EDTClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue EstimatesClearPoint Neuro (CLPT) delivered earnings and revenue surprises of +25.00% and -3.40%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Sep 10, 9:15 PM EDTLivaNova Director Sells 1,650 Shares for $131,500The sale was valued at approximately $131,500.
- Zacks · Aug 17, 1:17 PM EDTNeuroPace Faces an IGE Delay: What the FDA Setback Means for GrowthNPCE's IGE expansion faces a regulatory delay, shifting focus to rising RNS adoption as the company works through the FDA review process.
- Zacks · Aug 17, 1:06 PM EDTIs NeuroPace a Buy as Growth Improves but Valuation Stays Elevated?NPCE's stronger RNS adoption, narrowing losses and AI expansion support growth, but premium valuation, liquidity and regulatory risks warrant patience.
- Zacks · Aug 17, 12:59 PM EDTNPCE Is Down 12.7% in 3 Months: Is the Pullback a Buying Opportunity?NeuroPace's stronger RNS growth, raised 2026 guidance and AI expansion face a less certain IGE regulatory path after the FDA setback.
- The Motley Fool · Aug 12, 11:34 AM EDTLivaNova (LIVN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 6, 12:31 PM EDTLivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook RaisedLIVN's Q2 earnings and revenues beat estimates as Cardiopulmonary and Epilepsy growth fuels margin gains and a raised 2026 outlook.
- Zacks · Aug 5, 2:00 PM EDTINSP Raises 2026 Outlook as Reimbursement Headwinds Start to EaseInspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.
- MarketBeat · Aug 5, 1:04 PM EDTLivaNova Q2 Earnings Call HighlightsLivaNova (NASDAQ:LIVN) reported record quarterly revenue and adjusted earnings per share for the second quarter of 2026, citing double-digit reported growth across its Cardiopulmonary and Epilepsy businesses. The company raised its full-year revenue and adjusted EPS outlook while
- Zacks · Aug 5, 9:30 AM EDTLivaNova (LIVN) Reports Q2 Earnings: What Key Metrics Have to SayWhile the top- and bottom-line numbers for LivaNova (LIVN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- Zacks · Aug 5, 9:15 AM EDTLivaNova PLC (LIVN) Hits Fresh High: Is There Still Room to Run?LivaNova (LIVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Zacks · Aug 5, 7:25 AM EDTLivaNova (LIVN) Q2 Earnings and Revenues Beat EstimatesLivaNova (LIVN) delivered earnings and revenue surprises of +16.67% and +2.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for LivaNova PLC from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.